Gupta R - Search Results

1

Prioritization of Generic Drug Review-Reply.

Gupta R, Kesselheim AS, Ross JS. Gupta R, et al. JAMA Intern Med. 2017 Jan 1;177(1):141-142. doi: 10.1001/jamainternmed.2016.7817. JAMA Intern Med. 2017. PMID: 28030736 No abstract available.

2

Generic Drug Approvals Since the 1984 Hatch-Waxman Act.

Gupta R, Kesselheim AS, Downing N, Greene J, Ross JS. Gupta R, et al. JAMA Intern Med. 2016 Sep 1;176(9):1391-3. doi: 10.1001/jamainternmed.2016.3411. JAMA Intern Med. 2016. PMID: 27428055 No abstract available.

3

The FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United States.

Gupta R, Dhruva SS, Fox ER, Ross JS. Gupta R, et al. J Manag Care Spec Pharm. 2017 Oct;23(10):1066-1076. doi: 10.18553/jmcp.2017.23.10.1066. J Manag Care Spec Pharm. 2017. PMID: 28944731

4

High Costs of FDA Approval for Formerly Unapproved Marketed Drugs.

Hakim A, Gupta R, Ross JS. Hakim A, et al. Among authors: gupta r. JAMA. 2017 Dec 12;318(22):2181-2182. doi: 10.1001/jama.2017.16481. JAMA. 2017. PMID: 29131905 No abstract available.

5

Affordability and availability of off-patent drugs in the United States-the case for importing from abroad: observational study.

Gupta R, Bollyky TJ, Cohen M, Ross JS, Kesselheim AS. Gupta R, et al. BMJ. 2018 Mar 19;360:k831. doi: 10.1136/bmj.k831. BMJ. 2018. PMID: 29555641 Free PMC article.

6

The Impact of Off-Patent Drug Acquisitions on Prices.

Gupta R, Henkel A, Forman HP, Ross JS. Gupta R, et al. J Gen Intern Med. 2018 Jul;33(7):1007-1009. doi: 10.1007/s11606-018-4372-3. J Gen Intern Med. 2018. PMID: 29687433 Free PMC article. No abstract available.

7

Generic Drugs in the United States: Policies to Address Pricing and Competition.

Gupta R, Shah ND, Ross JS. Gupta R, et al. Clin Pharmacol Ther. 2019 Feb;105(2):329-337. doi: 10.1002/cpt.1314. Epub 2019 Jan 10. Clin Pharmacol Ther. 2019. PMID: 30471089 Free PMC article.

8

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration.

Jiao K, Gupta R, Fox E, Kesselheim A, Ross JS. Jiao K, et al. Among authors: gupta r. JAMA Netw Open. 2019 Oct 2;2(10):e1913029. doi: 10.1001/jamanetworkopen.2019.13029. JAMA Netw Open. 2019. PMID: 31603482 Free PMC article.

9

Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics.

Vijay A, Gupta R, Liu P, Dhruva SS, Shah ND, Ross JS. Vijay A, et al. Among authors: gupta r. J Gen Intern Med. 2020 Jun;35(6):1928-1930. doi: 10.1007/s11606-019-05432-6. Epub 2019 Oct 17. J Gen Intern Med. 2020. PMID: 31625043 Free PMC article. No abstract available.

10

The Rising Price of Naloxone - Risks to Efforts to Stem Overdose Deaths.

Gupta R, Shah ND, Ross JS. Gupta R, et al. N Engl J Med. 2016 Dec 8;375(23):2213-2215. doi: 10.1056/NEJMp1609578. N Engl J Med. 2016. PMID: 27959694 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results